182 related articles for article (PubMed ID: 36745434)
21. Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy.
Chen Z; Liu W; Yang Z; Luo Y; Qiao C; Xie A; Jia Q; Yang P; Wang Z; Zhang R
Theranostics; 2023; 13(5):1571-1583. PubMed ID: 37056565
[No Abstract] [Full Text] [Related]
22. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy.
Li F; Zhang XQ; Ho W; Tang M; Li Z; Bu L; Xu X
Nat Commun; 2023 Jul; 14(1):4223. PubMed ID: 37454146
[TBL] [Abstract][Full Text] [Related]
23. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death.
Shi J; Gao W; Shao F
Trends Biochem Sci; 2017 Apr; 42(4):245-254. PubMed ID: 27932073
[TBL] [Abstract][Full Text] [Related]
24. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro.
Yu P; Wang HY; Tian M; Li AX; Chen XS; Wang XL; Zhang Y; Cheng Y
Acta Pharmacol Sin; 2019 Sep; 40(9):1237-1244. PubMed ID: 30914761
[TBL] [Abstract][Full Text] [Related]
25. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
[TBL] [Abstract][Full Text] [Related]
26. Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance.
Li J; Ding B; Tan J; Chen H; Meng Q; Li X; Zheng P; Ma P; Lin J
Nano Lett; 2023 Nov; 23(21):10034-10043. PubMed ID: 37903236
[TBL] [Abstract][Full Text] [Related]
27. Gasdermin: A new player to the inflammasome game.
Ramos-Junior ES; Morandini AC
Biomed J; 2017 Dec; 40(6):313-316. PubMed ID: 29433834
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency-Activated Pyroptosis of Bi-Valent Gold Nanocluster for Cancer Immunotherapy.
Zhang Q; Shi D; Guo M; Zhao H; Zhao Y; Yang X
ACS Nano; 2023 Jan; 17(1):515-529. PubMed ID: 36580577
[TBL] [Abstract][Full Text] [Related]
29. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma.
Hsieh HT; Huang HC; Chung CW; Chiang CC; Hsia T; Wu HF; Huang RL; Chiang CS; Wang J; Lu TT; Chen Y
J Control Release; 2022 Dec; 352():920-930. PubMed ID: 36334859
[TBL] [Abstract][Full Text] [Related]
30. An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway.
Feng Z; Chen G; Zhong M; Lin L; Mai Z; Tang Y; Chen G; Ma W; Li G; Yang Y; Yu Z; Yu M
Biomaterials; 2023 Nov; 302():122333. PubMed ID: 37738743
[TBL] [Abstract][Full Text] [Related]
31. Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma.
Lei S; Li H
Curr Eye Res; 2022 Jun; 47(6):930-943. PubMed ID: 35348009
[TBL] [Abstract][Full Text] [Related]
32. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
[TBL] [Abstract][Full Text] [Related]
33. Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy.
Sun S; He Y; Xu J; Leng S; Liu Y; Wan H; Yan L; Xu Y
J Control Release; 2024 Mar; 367():470-485. PubMed ID: 38290565
[TBL] [Abstract][Full Text] [Related]
34. 'Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death.
Qiu S; Liu J; Xing F
Cell Death Differ; 2017 Apr; 24(4):588-596. PubMed ID: 28362726
[TBL] [Abstract][Full Text] [Related]
35. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.
Medina-Gutiérrez E; García-León A; Gallardo A; Álamo P; Alba-Castellón L; Unzueta U; Villaverde A; Vázquez E; Casanova I; Mangues R
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612081
[TBL] [Abstract][Full Text] [Related]
36. A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity.
Tao N; Jiao L; Li H; Deng L; Wang W; Zhao S; Chen W; Chen L; Zhu C; Liu YN
ACS Nano; 2023 Nov; 17(22):22844-22858. PubMed ID: 37942890
[TBL] [Abstract][Full Text] [Related]
37. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.
Núñez Y; Garcia-León A; Falgàs A; Serna N; Sánchez-García L; Garrido A; Sierra J; Gallardo A; Unzueta U; Vázquez E; Villaverde A; Mangues R; Casanova I
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986589
[TBL] [Abstract][Full Text] [Related]
38. No longer married to inflammasome signaling: the diverse interacting pathways leading to pyroptotic cell death.
Weir A; Vince JE
Biochem J; 2022 May; 479(10):1083-1102. PubMed ID: 35608339
[TBL] [Abstract][Full Text] [Related]
39. Coral gasdermin triggers pyroptosis.
Jiang S; Zhou Z; Sun Y; Zhang T; Sun L
Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33277371
[TBL] [Abstract][Full Text] [Related]
40. Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.
Lee CH; Kakinuma T; Wang J; Zhang H; Palmer DC; Restifo NP; Hwang ST
Mol Cancer Ther; 2006 Oct; 5(10):2592-9. PubMed ID: 17041104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
